K4 Elite logo K4 Elite
Home / Catalog / Ipamorelin

Ipamorelin

Growth Hormone Secretagogue

IpamorelinIpamorelin chemical structure
Research overview

Ipamorelin is a small lab-made peptide (a short chain of just five amino acids, the building blocks of proteins). In studies it is described as one of the first compounds that very selectively prompts the body to release growth hormone. It belongs to a group of compounds that mimic ghrelin (a natural body hormone often called the hunger hormone) and has been used as a research tool to study selective growth-hormone release.

How it works

Ipamorelin switches on the ghrelin receptor, known by the code name GHS-R1a (the docking point on cells that the hunger hormone ghrelin normally acts through). Turning it on is studied for prompting the pituitary gland (a small gland at the base of the brain) to release growth hormone, through a path separate from the GHRH pathway (the other main way growth hormone release is triggered) [1]. A key point reported in the first studies is how selective it is: it prompted growth-hormone release without meaningfully raising other hormones such as ACTH, cortisol (the stress hormone), or prolactin, even at doses well above what was needed for the growth-hormone effect [1].

What researchers have studied it for: the growth hormone and IGF-1 system

In awake animals, ipamorelin was reported to prompt a clear, dose-related release of growth hormone, and researchers have used it to compare growth-hormone release driven by the ghrelin receptor with release driven by GHRH [1]. Because it is so selective, it is a common research tool for studying ghrelin-receptor effects on the growth hormone and IGF-1 system (IGF-1 is a growth signal triggered by growth hormone) without stress hormones getting in the way [1].

What researchers have studied it for: body composition and bone

Animal studies have looked at compounds of this type for effects on measures such as body-weight gain and bone mineral, to study the downstream results of prompted growth-hormone release [1].

What the research hasn't shown yet

The supporting evidence is mostly from animal and mechanism studies. The research does not show that this compound is safe or effective for any one person who buys it, and no benefit to the buyer is implied. Ipamorelin is supplied by K4 Elite only as a reference compound for laboratory and test-tube research, not for any other use.

Molecular data
Molecular formulaC38H49N9O5
Molecular weight711.9 g/mol
PubChemCID 9831659 ↗
Reconstitution, storage & handling

In laboratory settings the lyophilized peptide is typically reconstituted with bacteriostatic or sterile water to the desired concentration. Store the lyophilized powder at -20°C, keep reconstituted solution at 2-8°C, minimize freeze-thaw cycles, and protect from light to preserve peptide integrity.

Research FAQ
What is ipamorelin?
It is a small lab-made peptide described as one of the first compounds that selectively prompts growth-hormone release, acting like the hunger hormone ghrelin.
What receptor does it act on?
It switches on the ghrelin receptor (code name GHS-R1a), the docking point that the body's own ghrelin normally acts through.
Why is its selectivity notable in research?
Early studies reported it prompted growth-hormone release without meaningfully raising stress-related hormones (ACTH, cortisol, or prolactin), which makes it useful for isolating ghrelin-receptor effects.
Is a benefit for people shown?
No. The supporting data are mostly from animal and mechanism studies and do not show that it is safe or effective for any one person.
Is this product meant for people to use?
No. It is supplied only for test-tube research, and is not for use in humans or animals.
References (research only)
Related research on K4 Elite
Browse the full store →
Research use only. Ipamorelin is sold strictly for in-vitro laboratory and research purposes. Not for human or veterinary use, and not for diagnostic or therapeutic applications. This product has not been evaluated by the FDA. No statement on this page should be construed as a medical claim.